Sotsiaalministeerium · 4. veebruar 2019
Sisu (failidest)
Roadmap to scale up the HIV
response
Estonia
Introduction
This roadmap for the response to HIV in Estonia reaffirms Estonia’s commitment to the United Nations political
declaration on HIV and AIDS: ‘On the fast track to accelerate the fight against HIV and to end the AIDS epidemic by
2030’ and presents the HIV epidemiology, country achievements, and key interventions to reach the agreed targets for
20201 set by the Joint United Nations Programme on HIV/AIDS (UNAIDS), the ‘Action plan for the health sector
response to HIV in the WHO European Region’ and the WHO ‘Global health sector strategy on HIV for 2016–2021’.
The development of the Country Roadmaps are a follow-up action from the ‘Ministerial policy dialogue on HIV and
related co-morbidities in eastern Europe and central Asia’ that was held in July 2018 in Amsterdam, the Netherlands.
Recognizing HIV as a public health concern in Estonia and the importance of political commitment to accelerate and
scale up the response to the HIV epidemic to reach the 2020 targets, this roadmap outlines prevention, treatment, care
and support actions that help to reduce the number of new HIV infections, increase life expectancy and quality of life,
and promote and protect human rights and the dignity of all people living with, at risk of, and affected by HIV and
AIDS and their families.
This roadmap was prepared by the Ministry of Social Affairs of Estonia, National Institute for Health Development.
Epidemiology
HIV started to spread rapidly in Estonia in the beginning of the 2000s, when the number of new HIV cases registered
per year more than tripled in in 2001 reaching 108 cases per 100 000 population (Health Board). Since then, the number
of new HIV cases has been stably decreasing over the years (NIHD; Health Board).
The exact number of people living with HIV (PLHIV) in Estonia is not known due to the anonymous testing (including
confirmatory testing) carried out in 2000–2008 (NIHD & Health Board), but based on a Spectrum analysis carried out
in 2015 the number is prognosed to be approximately 7 700 (Sandre et al., 2016). In 2017, approximately 4 600 people
were aware of their diagnosis and registered with an infectious disease specialist and approximately 4 100 (89%) of
them received antiretroviral treatment (ART) Of those, 87.3% had an undetectable viral load (<200 copies/mL)
(Ministry of Social Affairs of Estonia).
In 2017, 219 new HIV cases were registered, with over 70% occurring in people aged over 30. The proportion of
women among newly diagnosed HIV patients was 33% and it has been relatively stable in the last 15 years (33–42%;
Health Board). The main route of transmission was heterosexual intercourse (39.7% of new HIV cases). Homosexual
intercourse accounted for 6.8% of the cases and 6.4% were related to injecting drug use (Health Board).
Among key populations, HIV prevalence is the highest among people who inject drugs (PWID) (in the range of 48–
66%) and lowest among men who have sex with men (MSM) (between 2 and 4%) (NIHD). Among other key
populations (sex workers and people in detention facilities), the prevalence is lower than 16% (NIHD; Ministry of
Justice of Estonia).
Cumulatively since 1988, 537 people have been diagnosed with AIDS in Estonia. Based on the data for 2009–2017, on
average 29 people were diagnosed with AIDS every year (Health Board).
Achievements
The new ‘National HIV action plan 2017–2025’ was developed and approved by the Government in 2017 (Ministry of
Social Affairs, 2017).
In Estonia, HIV testing (including anonymous voluntary counselling and testing), ART and other outpatient services
provided by an infectious disease specialist are free of charge for all PLHIV (regardless of health insurance coverage).
Nevertheless, a standard visit fee of five euros is applied for outpatient services provided by the infectious disease
specialist (only applicable every three months). The funding of HIV testing carried out by primary health care
specialists is organized outside of their usual therapeutic fund in order to promote testing and earlier detection of the
infection. Starting from 2015, it is recommended that ART is started immediately after receiving an HIV diagnosis
regardless of the CD4 cell count. Four out of five treatment centres providing ART (excluding prisons) offer case
management services (social, psychological and peer counselling). Free treatment and infant milk formula are provided
1
By 2020, 90% of all people living with HIV will know their HIV status; 90% of all people with diagnosed HIV infection will receive sustained
antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression.
for all women and infants in need in order to prevent HIV transmission from mother to child, which has resulted in
ending the vertical spread of HIV in Estonia (0% in the last three years).
To reduce the spread of HIV among PWID, Estonia has gradually expanded the harm reduction service network, which
in 2017 included 34 harm reduction sites in different regions of Estonia (14 stationary centres and 20 outreach). As of
November 2018, two mobile units are offering harm reduction services in the two regions of Estonia with the highest
prevalence of HIV. Since 2013, harm reduction services include a take-home naloxone programme. In addition, since
2005, opioid substitution treatment has been provided in all prisons.
To reduce the spread of HIV among sex workers, sexual health counselling is provided for sex workers at three
designated sites with one also offering diagnostic and treatment services for sexually transmitted infections (STIs). The
harm reduction service network will continue to expand in Estonia as additional funding has been allocated for the
following four years.
Key action points to address the main challenges and gaps
Despite the progress made, important challenges remain: the proportion of new HIV cases per 100 000 population has
decreased over the years, but is still one of the highest in the European Union and although HIV testing and treatment
are relatively easily accessible in Estonia we have not yet reached the 90-90-90 targets. To reach these targets and
substantially reduce the proportion of new HIV cases per 100 000 population, there are five key aspects that need to be
improved: reaching out to PLHIV that are unaware of their diagnosis, accessibility, linkage between the services,
retention in care and awareness.
In order to make HIV testing even more accessible and ensure linkage to care there are two measures that will be taken:
Promotion of HIV testing and linkage to care according to designated guidelines that set specific
recommendations for these actions taking into account the health professions that may come into contact with
PLHIV (in order to promote HIV testing by health professionals other than infectious disease specialists) and
geographical differences in the spread of HIV in Estonia.
Scale-up of the community-based HIV testing and counselling.
In order to make HIV treatment and counselling more accessible and improve retention in care there are four key
measures that will be taken:
Develop new clinical guidelines based on the most recent WHO and European AIDS Clinical Society
recommendations.
Ensure ART medication and treatment services for PLHIV (including people in detention facilities and people
without health insurance) based on new clinical guidelines.
Extend the availability of free of charge case management systems (e.g. a team of experts consisting of a social
worker, peer counsellor and psychologist, who offer supportive services in HIV treatment centres) in order to
reduce the workload of case managers by ensuring the limit of approximately 250 patients per case manager
per month.
Provide easily accessible and integrated services, such as ART combined with harm reduction services and
drug addiction treatment (e.g. opioid substitution treatment) in order to promote retention among PWID. At
least one additional centre offering integrated ART and opioid substitution treatment services will be
established in the coming years.
In order to prevent HIV from spreading there are two important matters to be addressed:
1. Prevention of HIV among key populations (PWID, MSM, sex workers and people in detention facilities).
Provide harm reduction services, including the community-based provision of a life-saving drug (naloxone) to
PWID that is free of charge, accessible and provided to at least 60% of the estimated population.
Offer treatment and counselling services for addiction (including opioid substitution treatment) to PWID that
are free of charge, accessible and provided to at least 20% of the estimated population and implement
treatment as an alternative to coercive sanctions.
Expand comprehensive HIV prevention services to provide key populations with sexual health counselling,
testing for HIV and hepatitis, distribution of condoms and diagnostics and treatment of STIs that are free of
charge and easily accessible.
Develop guidelines for pre-exposure prophylaxis (PrEP) and ensure the availability of PrEP and post-exposure
prophylaxis.
2. Reduction of HIV-related stigma and discrimination in society.
Raise awareness about HIV and its transmission modes among the population and improve people’s
knowledge and life skills and encourage attitudes that promote safe sexual behaviour. This includes campaigns
carried out at least twice a year, a designated webpage that gathers up-to-date information about HIV and all
the services and educational programmes offered in schools.
Increase the knowledge and skills of HIV-related professionals by organizing training for pharmacists, social
workers, teachers and psychologists.
Provide sexual health counselling, STI diagnostics and treatment for young people up to 26 years of age in
designated youth counselling centres.
In order to monitor and evaluate the epidemiological situation there are three key measures that will be taken:
Detailed information about the course and outcome of HIV treatment is integrated into the national health
management information system.
Integrated HIV bio-behavioural surveillance surveys are regularly performed among key populations: among
PWID every 4 years, MSM every 3 years, and sex workers every 5 years.
The quality of data concerning the transmission mode and CD4 cell count, and the collection of this data is
improved to 80%.
Funding
In Estonia, the majority of the services tailored to tackle the HIV epidemiological situation have stable funding from the
State Budget granted by the Government of Estonia. Depending on the services, the funding falls under one of the five
different funding schemes:
1. Health care services and HIV testing in health care settings (excluding prisons) are financed though the
Estonian Health Insurance Fund and the services are provided to PLHIV with health insurance.
2. Health care services provided by infectious disease specialists and HIV testing in health care settings
(excluding prisons) offered to PLHIV without health insurance are provided analogously to PLHIV with health
insurance, but the services are financed by the Ministry of Social Affairs of Estonia.
3. Health care services (excluding ART) and HIV testing in prisons are financed by the Ministry of Justice of
Estonia.
4. ART medicines are centrally procured and distributed to treatment centres (including prisons) by the Ministry
of Social Affairs of Estonia (from 2019 by the Estonian Health Insurance Fund).
5. Services tailored to key populations and prevention of HIV are coordinated and financed by the National
Institute for Health Development (NIHD).
In 2018, the budget for ART procured by the Ministry of Social Affairs and HIV services for key populations financed
by NIHD collectively increased by 26% (to 20.1 million euros). In 2019 the budget for HIV services for key
populations financed by NIHD is set to increase even more, by 11% (to 5.3 million euros).
Elaboration of the document
This document was prepared by national experts:
Tiina Drell, Adviser, Public Health Department, Ministry of Social Affairs
Aljona Kurbatova, Head of the Centre for Prevention of Drug Addiction and Infectious Diseases, National Institute for
Health Development.
Sources
Health Board of Estonia (https://www.terviseamet.ee/en)
Ministry of Justice of Estonia (https://www.just.ee/en)
Ministry of Social Affairs of Estonia (http://www.sm.ee/en)
Ministry of Social Affairs of Estonia (2017). National HIV Action Plan 2017–2025, Tallinn.
(https://www.sm.ee/sites/default/files/content-editors/sisekomm/national_hiv_action_plan_2017-2025.pdf)
NIHD (National Institute for Health Development).
(http://www.tai.ee/en/publications?limit=15&filter_catid=30&filter_year=0&filter_typeid=0&filter_languageid=0&filte
r=&filter_order=p.publish_year&filter_order_Dir=DESC)
Sandre S-L, Kallaste E, Anspal S, Sõmer M (2016). Proliferation of HIV in the coming years and the cost to the state
[Estonian]. Tallinn, Center for Applied Research.
WHO (2016). Global health sector strategy on HIV for 2016–2021. Geneva. (https://www.who.int/hiv/strategy2016-
2021/ghss-hiv/en/)
WHO Regional Office for Europe (2017). Action plan for the health sector response to HIV in the WHO European
Region, Copenhagen.